Andrew Huberman separates the effects of nicotine from the harms of smoking and vaping, explaining how nicotine acts on brain pathways to boost dopamine, focus, and alertness. He details the neurochemistry of addiction, outlines why vaping is particularly addictive due to rapid dopamine release, and reviews evidence-based methods for quitting, including clinical hypnosis and pharmacologic approaches.
Summarized by Podsumo
Nicotine triggers dopamine release in the mesolimbic reward pathway, increasing motivation and well-being, but this effect is short-lived and leads to cravings and withdrawal.
Vaping delivers nicotine faster than smoking, causing a steeper dopamine spike that makes it more addictive and harder to quit.
70% of cigarette smokers want to quit, but only 5% succeed cold turkey; clinical hypnosis boosts success to 23% with a single session.
Nicotine itself is not a carcinogen; the thousands of toxins in tobacco and the damage from delivery devices cause cancer and vascular harm.
The first week of quitting is critical because baseline mood and arousal drop below normal, but using multiple cessation methods (patches, gum, hypnosis) can improve outcomes.
"Nicotine triggers the release of dopamine from the nucleus accumbens. This is what gives nicotine its rewarding properties. It increases motivation. It tends to give a not so subtle but very transient increase in feelings of well-being and alertness."
"The speed of onset of nicotine is going to also determine the speed of release of dopamine in the nucleus accumbens and ventral tegmental area, that mesolimbic reward pathway."
"If you can get through that first week, chances are quite a bit higher that you'll be able to maintain the cessation of smoking or vaping."